Article
Subtenon Autologous Platelet-Rich Plasma in Degenerative Retinal Diseases: A Prospective Comparative Pilot Study in Retinitis Pigmentosa and Extensive Macular Atrophy with Pseudodrusen-Like Appearance
2026-02-05
Abstract excerpt
<h4>Purpose: </h4> To evaluate the safety, feasibility, and functional outcomes of subtenon autologous platelet-rich plasma (PRP) in patients with retinitis pigmentosa (RP) and Extensive Macular Atrophy with Pseudodrusen-like Appearance (EMAP), two degenerative retinal diseases sharing convergent inflammatory and neurodegenerative pathways. <h4>Methods:</h4> This prospective, comparative pilot study included adult...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fad5df04-1bc3-52d7-b9d9-0b1b25923649
- DOI
- 10.20944/preprints202602.0412.v1
